Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07225647 | A Study to Assess the Effect of Food on the Drug Levels of Admilparant | PHASE1 | COMPLETED | 56 | — | — | Nov 7, 2025 | Jan 5, 2026 | Jan 14, 2026 | 2 | United States |
| Arm | Type | Description |
|---|---|---|
| Part 1: Treatment A | EXPERIMENTAL | - |
| Part 1: Treatment B | EXPERIMENTAL | - |
| Part 2: Treatment C | EXPERIMENTAL | - |
| Part 2: Treatment D | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Admilparant | DRUG | Specified dose on specified days |
Inclusion Criteria * Participants must have a body mass index (BMI) of 18.0 kg/m2 to 32.0 kg/m2, inclusive, at screening. * Participants must have a body weight of ≥ 50 kg for males and ≥ 45 kg for females at screening. Exclusion Criteria * Participants must not have any significant medical condi...